CDC Director Rochelle Walensky will resign in June

CDC Director Rochelle Walensky will resign in June


Director of the Centers for Disease Control Rochelle Walensky departs after testifying before the Senate Committee on Health, Education, Labor and Pensions on the All-Hazards Preparedness Act at the Dirksen Senate Office Building on Thursday, May 4, 2023 in Washington, DC.

Kent Nishimura | Los Angeles Times | Getty Images

CDC Director Dr. Rochelle Walensky on Friday announced that she will resign in at the end of June, ending a tenure marked by repeated change to adapt to an evolving coronavirus crisis.

Walensky did not provide a specific reason for her departure, but noted in a letter to President Joe Biden that the U.S. is transitioning out of the emergency of the Covid-19 response.

“The end of the COVID-19 public health emergency marks a tremendous transition for our country, for public health, and in my tenure as CDC Director,” Walensky wrote in the letter.

“I took on this role, at your request, with the goal of leaving behind the dark days of the pandemic and moving CDC – and public health – forward into a much better and more trusted place,” she said.

Biden, in a statement, thanked Walensky for her service.

“Dr. Walensky leaves CDC a stronger institution, better positioned to confront health threats and protect Americans,” the president said.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Walensky assumed leadership of the battered agency in early 2021 as the U.S. was rolling out its Covid vaccination campaign. She helmed the public health agency while the national pandemic response faced repeated setbacks from the emergence of the delta and omicron variants.

The U.S. public health emergency will end on Thursday. The World Health Organization on Friday declared an end to the global Covid health emergency.

Walensky acknowledged in August 2022 that the CDC’s response to the pandemic was inadequate. She launched a reorganization that sought to make the agency faster at responding to disease threats and improve its communication of health guidance to the public.

But the CDC still struggles to respond to public health threats due to limited authority in the face of a fragmented health-care system. The agency will have less data to track Covid and new variants when the public health emergency expires because it cannot compel states to report this information.

Walensky also helped lead the U.S. response to the sudden outbreak of mpox in the summer of 2022.

She lead the infectious disease division at Massachusetts General Hospital and was a professor of medicine at Harvard Medical School before joining the Biden administration. Walensky is an expert on HIV.



Source

FDA taps biotech industry veteran as RFK Jr.’s top drug regulator 
Health

FDA taps biotech industry veteran as RFK Jr.’s top drug regulator 

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters The Food and Drug Administration said on Monday it has appointed former biotech executive George Tidmarsh as the agency’s top drug regulator. Tidmarsh, an adjunct professor of pediatrics and neonatology […]

Read More
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Health

Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn’t until 2021 when she was diagnosed with […]

Read More
Sarepta shares plunge 40% as future of its gene therapy appears at risk
Health

Sarepta shares plunge 40% as future of its gene therapy appears at risk

Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk. The […]

Read More